Corcept Therapeutics Incorporated revenue breakdown overview

Corcept Therapeutics Incorporated revenue for the last year amounted to 675.04 M USD, the most of which — 675.04 M USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 482.38 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Corcept Therapeutics Incorporated 675.04 M USD, and the year before that — 482.38 M USD.